Theravance Inc (NASDAQ:THRX)

18.02
BATS BZX Real-Time Price
As of 1:27pm ET
 -0.075 / -0.41%
Today’s Change
10.58
Today|||52-Week Range
31.80
+27.35%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M-18.23%
Glaxosmithkline Plc
Buy3/02/201592,674$19.22$1.8M-5.85%
Glaxosmithkline Plc
Buy5/11/201585,579$16.00$1.4M+12.39%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M-20.04%
Shafer Bradford J
General Counsel & Senior Vice President
Sale8/11/201427,108$22.12$599.6K-18.23%
Shafer Bradford J
General Counsel & Senior Vice President
Buy8/11/201433,667$14.53$489.2K-18.23%
Aguiar Michael W
President & Chief Executive Officer
Sale6/02/201524,698$16.68$412.0K+8.48%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201424,338$12.66$308.1K-20.04%
Lee Junning
Senior Vice President-Technical Operations
Buy8/13/201423,705$12.66$300.1K-20.04%
Waltrip William H
Director
Sale5/27/201516,313$16.32$266.2K+7.07%
Page of 4

To view my watchlist

Not a member yet?

Sign up now for a free account